Literature DB >> 10328042

A short questionnaire (IRQ) to assess injecting risk behaviour.

G V Stimson1, S Jones, C Chalmers, D Sullivan.   

Abstract

AIM: To develop a short injecting risk questionnaire (IRQ) to measure sharing of injecting equipment.
DESIGN: Matrix design with quota assignment, designed to compare the questionnaire when used by interview and self-completion, in agency and community settings, by agency staff and fieldworkers, with different injectors (age < 26 vs. 26+; male vs. female, opiate vs stimulant injectors), and in different geographical areas. SETTINGS: Drug treatment and helping agencies, and community settings, in England. PARTICIPANTS: Drug users who had injected in the last 4 weeks. MEASUREMENTS: Questions measured different aspects of equipment sharing. Questionnaire performance assessed by question acceptability, test-retest (parallel forms) reliability, inter-rater reliability, inter-instrument reliability, internal reliability, construct validity and internal collateral validity. Statistical tests included product moment correlation, principal components analysis, and Cronbach's alpha.
FINDINGS: The questionnaire was highly acceptable. Test-retest correlations were all high and significant, questions performed well in all conditions, with no differences by site (agency vs. out-of-contact), order (interview or self-completion first), administration (staff vs. fieldworker), elapsed time or subject characteristics. The questionnaire had high internal reliability (Cronbach's alpha > +0.86), and items measured a similar domain with all questions loading highly (> 0.32) on a single factor which accounted for > 42% of the variance. The complete IRQ elicited higher reports of equipment sharing (77%) than a single question (56%).
CONCLUSIONS: IRQ performs well in a variety of settings, when administered in different ways to different kinds of IDUs. A single question on 'sharing' elicits fewer positive responses than the use of multiple questions about different sharing practices.

Entities:  

Mesh:

Year:  1998        PMID: 10328042     DOI: 10.1046/j.1360-0443.1998.9333373.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  7 in total

1.  Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?

Authors:  V D Hope; A Judd; M Hickman; T Lamagni; G Hunter; G V Stimson; S Jones; L Donovan; J V Parry; O N Gill
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

2.  Effects of sex work on the prevalence of syphilis among injection drug users in 3 Russian cities.

Authors:  Lucy Platt; Tim Rhodes; Ali Judd; Evgeniya Koshkina; Svetlana Maksimova; Natalia Latishevskaya; Adrian Renton; Tamara McDonald; John V Parry
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

3.  The effectiveness of behavioural interventions in the primary prevention of hepatitis C amongst injecting drug users: a randomised controlled trial and lessons learned.

Authors:  Mohammed Abou-Saleh; Paul Davis; Philip Rice; Ken Checinski; Colin Drummond; Douglas Maxwell; Christine Godfrey; Christopher John; Betsy Corrin; Christopher Tibbs; Adenekan Oyefeso; Marian de Ruiter; Hamid Ghodse
Journal:  Harm Reduct J       Date:  2008-07-31

4.  Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia.

Authors:  Lucy Platt; Martin Wall; Tim Rhodes; Ali Judd; Matthew Hickman; Lisa G Johnston; Adrian Renton; Natalia Bobrova; Anya Sarang
Journal:  J Urban Health       Date:  2006-11       Impact factor: 3.671

5.  Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK.

Authors:  Nicholas Lintzeris; John Strang; Nicola Metrebian; Sarah Byford; Christopher Hallam; Sally Lee; Deborah Zador
Journal:  Harm Reduct J       Date:  2006-09-27

6.  Quantifying hepatitis C transmission risk using a new weighted scoring system for the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ): applications for community-based HCV surveillance, education and prevention.

Authors:  Mark A Stoové; Craig L Fry; Nicholas Lintzeris
Journal:  Harm Reduct J       Date:  2008-04-23

7.  A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design.

Authors:  Marie Jauffret-Roustide; Yann Le Strat; Elisabeth Couturier; Damien Thierry; Marc Rondy; Martine Quaglia; Nicolas Razafandratsima; Julien Emmanuelli; Gaelle Guibert; Francis Barin; Jean-Claude Desenclos
Journal:  BMC Infect Dis       Date:  2009-07-16       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.